Literature DB >> 1821660

Cardiovascular dysautonomia in fatal familial insomnia.

P Cortelli1, P Parchi, M Contin, G Pierangeli, P Avoni, P Tinuper, P Montagna, A Baruzzi, P L Gambetti, E Lugaresi.   

Abstract

Autonomic control of the cardiovascular system was assessed in two patients with Fatal Familial Insomnia. The diagnosis was confirmed at autopsy in patient 1. In the resting state blood pressure and heart rate were higher than controls in patient 1; plasma noradrenaline levels were elevated in both patients. Evaluation of cardiovascular reflexes indicated intact baroreflex pathways but with exaggerated blood pressure and biochemical responses to certain stimuli (postural change, Valsalva manoeuvre, isometric handgrip). There was no pressor response to intravenously infused noradrenaline, an increased response to atropine and diminished depressor and sedative effects to clonidine. Overall these results are indicative of an unbalanced autonomic control with preserved parasympathetic and higher background and stimulated sympathetic activity. These physiological, biochemical and pharmacological data, together with known neuro-pathological findings in this disorder, emphasize the possible role played by the thalamus in regulating autonomic control of cardiovascular function in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821660     DOI: 10.1007/BF01826053

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  8 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

Review 2.  Central alpha-adrenergic systems as targets for hypotensive drugs.

Authors: 
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

3.  Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei.

Authors:  E Lugaresi; R Medori; P Montagna; A Baruzzi; P Cortelli; A Lugaresi; P Tinuper; M Zucconi; P Gambetti
Journal:  N Engl J Med       Date:  1986-10-16       Impact factor: 91.245

4.  Thalamocortical and thalamo-amygdaloid projections from the parvicellular division of the posteromedial ventral nucleus in the cat.

Authors:  Y Yasui; K Itoh; T Sugimoto; T Kaneko; N Mizuno
Journal:  J Comp Neurol       Date:  1987-03-08       Impact factor: 3.215

Review 5.  Relationship between plasma norepinephrine and sympathetic neural activity.

Authors:  D S Goldstein; R McCarty; R J Polinsky; I J Kopin
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

6.  Comparison of techniques for measuring baroreflex sensitivity in man.

Authors:  D S Goldstein; D Horwitz; H R Keiser
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

7.  Efferent connections of the prelimbic (area 32) and the infralimbic (area 25) cortices: an anterograde tracing study in the cat.

Authors:  P Room; F T Russchen; H J Groenewegen; A H Lohman
Journal:  J Comp Neurol       Date:  1985-12-01       Impact factor: 3.215

8.  Rat medial frontal cortex: a visceral motor region with a direct projection to the solitary nucleus.

Authors:  R R Terreberry; E J Neafsey
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

  8 in total
  11 in total

1.  The classification and nomenclature of autonomic disorders--ending chaos, resolving conflict and hopefully achieving clarity.

Authors:  C J Mathias
Journal:  Clin Auton Res       Date:  1995-12       Impact factor: 4.435

2.  Functional dysautonomia: a valid clinical entity or pseudo-science?

Authors:  F Okada; S Minoshita
Journal:  Clin Auton Res       Date:  1994-08       Impact factor: 4.435

3.  Daytime baroreflex sensitivity in patients with primary insomnia.

Authors:  Jan Giso Peter; Martin Glos; Alexander Blau; Thomas Penzel; Gert Baumann; Ingo Fietze
Journal:  Clin Res Cardiol       Date:  2010-11-24       Impact factor: 5.460

Review 4.  Sympathetic neural responses to sleep disorders and insufficiencies.

Authors:  Ian M Greenlund; Jason R Carter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-07       Impact factor: 4.733

Review 5.  Agrypnia excitata.

Authors:  Federica Provini
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

6.  Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex.

Authors:  P Cortelli; P Parchi; M Contin; E Sforza; A Lugaresi; R Pasquali; E Lugaresi
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

7.  Distribution of cardiovascular related cells within the human thalamus.

Authors:  S M Oppenheimer; N Kulshreshtha; F A Lenz; Z Zhang; L H Rowland; P M Dougherty
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

Review 8.  A new prion disease: relationship with central and peripheral amyloidoses.

Authors:  Simon Mead; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

9.  Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions.

Authors:  Jing Zhang; Min Chu; ZiChen Tian; KeXin Xie; Yue Cui; Li Liu; JiaLi Meng; HaiHan Yan; Yang-Mingyue Ji; Zhuyi Jiang; Tian-Xinyu Xia; Dongxin Wang; Xin Wang; Ye Zhao; Hong Ye; Junjie Li; Lin Wang; Liyong Wu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-10-19       Impact factor: 10.154

10.  A novel prion disease associated with diarrhea and autonomic neuropathy.

Authors:  Simon Mead; Sonia Gandhi; Janice L Holton; John Collinge; Jon Beck; Diana Caine; Dillip Gallujipali; Christopher Carswell; Harpreet Hyare; Susan Joiner; Hilary Ayling; Tammaryn Lashley; Jacqueline M Linehan; Huda Al-Doujaily; Bernadette Sharps; Tamas Revesz; Malin K Sandberg; Mary M Reilly; Martin Koltzenburg; Alastair Forbes; Peter Rudge; Sebastian Brandner; Jason D Warren; Jonathan D F Wadsworth; Nicholas W Wood
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.